Moat Wideners
These companies are building unbeatable competitive advantages that competitors simply can't match. Our analysts have carefully selected businesses that prioritize long-term market dominance over quick profits, creating exceptional durability and growth potential.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
Amazon.com Inc.
AMZN
Current price
$228.01
Its massive e-commerce and logistics infrastructure, paired with its leading cloud platform (AWS), establishes formidable and continuously expanding c...
Its massive e-commerce and logistics infrastructure, paired with its leading cloud platform (AWS), establishes formidable and continuously expanding competitive barriers.
Alphabet Inc (Google)
GOOGL
Current price
$201.57
Unmatched dominance in search and digital advertising is fueled by a vast, proprietary data advantage and continuous, heavy investment in artificial i...
Unmatched dominance in search and digital advertising is fueled by a vast, proprietary data advantage and continuous, heavy investment in artificial intelligence.
Join Nemo FREE today and unlock every stock.
It only takes 60 seconds.
About This Group of Stocks
Our Expert Thinking
These companies are playing the long game, strategically reinvesting profits to strengthen their competitive advantages rather than maximizing short-term earnings. From proprietary technology to iconic brands and complex service networks, they're building business "moats" that get wider and deeper over time.
What You Need to Know
This collection focuses on resilient businesses capable of weathering economic uncertainty while maintaining pricing power. They typically have high barriers to entry, strong customer loyalty, or network effects that make them increasingly difficult to compete against as they grow, positioning them as core portfolio holdings.
Why These Stocks
Each company demonstrates disciplined capital allocation that reinforces its market leadership. In today's volatile economic landscape, these businesses aren't just defending their positions—they're actively gaining market share from weaker competitors while building foundations for tomorrow's success.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+7.58%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 7.58% over the next year.
Stocks Rated Buy by Analysts
14 of 14 assets in this group are rated Buy by professional analysts.
Group Growth
This group averaged a 3% return last month.
Why You'll Want to Watch These Stocks
The Ultimate Defense Play
These companies don't just survive market downturns—they often emerge stronger. Their wide competitive moats provide protection during economic uncertainty while allowing them to capture market share from weaker rivals.
Building Tomorrow's Giants Today
While others chase quarterly profits, these companies are investing in competitive advantages that could dominate their industries for decades. Their strategic vision often creates compounding growth that gets stronger over time.
The Sleep-Well Portfolio Foundation
Institutional investors and seasoned market veterans favor these durable businesses for their core holdings. Their robust competitive advantages and strategic reinvestment deliver the reliability that forms the backbone of quality investment portfolios.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
The New Cost of Compliance: Investing in HR Tech
Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.
GLP-1s Target Liver Disease
The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.
Pharma's Digital Prescription
Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.
Frequently Asked Questions
Everything you need to know about the product and billing.